Allen C. Gao

11.3k total citations · 1 hit paper
161 papers, 8.4k citations indexed

About

Allen C. Gao is a scholar working on Pulmonary and Respiratory Medicine, Molecular Biology and Oncology. According to data from OpenAlex, Allen C. Gao has authored 161 papers receiving a total of 8.4k indexed citations (citations by other indexed papers that have themselves been cited), including 97 papers in Pulmonary and Respiratory Medicine, 81 papers in Molecular Biology and 50 papers in Oncology. Recurrent topics in Allen C. Gao's work include Prostate Cancer Treatment and Research (96 papers), Hormonal and reproductive studies (22 papers) and Cancer, Lipids, and Metabolism (19 papers). Allen C. Gao is often cited by papers focused on Prostate Cancer Treatment and Research (96 papers), Hormonal and reproductive studies (22 papers) and Cancer, Lipids, and Metabolism (19 papers). Allen C. Gao collaborates with scholars based in United States, China and Canada. Allen C. Gao's co-authors include Wei Lou, Christopher P. Evans, Nagalakshmi Nadiminty, Chengfei Liu, Joy C. Yang, Yezi Zhu, Cameron M. Armstrong, Soo Ok Lee, Thenappan Chandrasekar and Ramakumar Tummala and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Nature Medicine.

In The Last Decade

Allen C. Gao

155 papers receiving 8.3k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Mechanisms of resistance in castration-resistant prostate cancer (CRPC).

2015 424 citations Thenappan Chandrasekar, Joy C. Yang et al. PubMed Central profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Allen C. Gao United States	54	4.4k	3.5k	2.7k	2.6k	839	161	8.4k
Natasha Kyprianou United States	49	3.9k 0.9×	2.7k 0.8×	2.0k 0.7×	1.7k 0.7×	605 0.7×	135	7.5k
Hiroki Kuniyasu Japan	54	5.4k 1.2×	1.6k 0.5×	3.1k 1.2×	2.2k 0.8×	645 0.8×	277	10.3k
Wei Lou United States	45	2.7k 0.6×	2.1k 0.6×	1.5k 0.5×	1.5k 0.6×	456 0.5×	111	5.2k
Brian D. Lehmann United States	35	5.7k 1.3×	2.1k 0.6×	5.7k 2.1×	4.4k 1.7×	931 1.1×	71	11.2k
Igor Vivanco United States	20	5.0k 1.1×	1.3k 0.4×	2.0k 0.7×	1.3k 0.5×	362 0.4×	28	7.0k
Anderson J. Ryan United Kingdom	42	3.9k 0.9×	1.4k 0.4×	2.9k 1.1×	1.5k 0.6×	450 0.5×	159	7.4k
Linda S. Steelman United States	49	7.5k 1.7×	1.1k 0.3×	3.3k 1.2×	1.9k 0.7×	495 0.6×	112	11.2k
Yasuo Miyoshi Japan	52	4.6k 1.0×	1.0k 0.3×	3.4k 1.3×	2.3k 0.9×	1.6k 1.9×	252	9.3k
Ming You United States	48	5.2k 1.2×	1.2k 0.3×	2.0k 0.7×	1.9k 0.7×	638 0.8×	198	8.0k
Yiwei Li United States	55	7.0k 1.6×	994 0.3×	3.9k 1.4×	3.6k 1.4×	679 0.8×	135	11.3k

Countries citing papers authored by Allen C. Gao

Since Specialization

Citations

This map shows the geographic impact of Allen C. Gao's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Allen C. Gao with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Allen C. Gao more than expected).

Fields of papers citing papers by Allen C. Gao

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Allen C. Gao. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Allen C. Gao. The network helps show where Allen C. Gao may publish in the future.

Co-authorship network of co-authors of Allen C. Gao

This figure shows the co-authorship network connecting the top 25 collaborators of Allen C. Gao. A scholar is included among the top collaborators of Allen C. Gao based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Allen C. Gao. Allen C. Gao is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Ning, Shu, Wei Lou, Alan P. Lombard, et al.. (2024). PINK1-Mediated Mitochondrial Activity Confers Olaparib Resistance in Prostate Cancer Cells. Cancer Research Communications. 4(11). 2976–2985.

Ullah, Asmat, Rashmi Verma, Allen C. Gao, et al.. (2024). A phase I/II study of enzalutamide in combination with indomethacin in men with castration-resistant prostate cancer (CRPC).. Journal of Clinical Oncology. 42(16_suppl). e17027–e17027. 1 indexed citations

Pu, Tianjie, Jinglong Zhang, Jingrui Chen, et al.. (2024). Stromal-derived MAOB promotes prostate cancer growth and progression. Science Advances. 10(6). eadi4935–eadi4935. 11 indexed citations

Chen, Bo, Pengfei Xu, Joy C. Yang, et al.. (2024). Plexin D1 emerges as a novel target in the development of neural lineage plasticity in treatment-resistant prostate cancer. Oncogene. 43(30). 2325–2337. 3 indexed citations

Ning, Shu, Cameron M. Armstrong, Wei Lou, et al.. (2023). Therapeutic Resistance Models and Treatment Sequencing in Advanced Prostate Cancer. Cancers. 15(21). 5273–5273. 3 indexed citations

Lombard, Alan P., Cameron M. Armstrong, Leandro S. D’Abronzo, et al.. (2022). Olaparib-Induced Senescence Is Bypassed through G2–M Checkpoint Override in Olaparib-Resistant Prostate Cancer. Molecular Cancer Therapeutics. 21(4). 677–685. 14 indexed citations

Yin, Lijuan, Jingjing Li, Jing Wang, et al.. (2021). Bidirectional Cross-talk between MAOA and AR Promotes Hormone-Dependent and Castration-Resistant Prostate Cancer. Cancer Research. 81(16). 4275–4289. 18 indexed citations

Armstrong, Cameron M., Chengfei Liu, Liangren Liu, et al.. (2020). Steroid Sulfatase Stimulates Intracrine Androgen Synthesis and is a Therapeutic Target for Advanced Prostate Cancer. Clinical Cancer Research. 26(22). 6064–6074. 17 indexed citations

Liu, Chengfei, Joy C. Yang, Cameron M. Armstrong, et al.. (2019). AKR1C3 Promotes AR-V7 Protein Stabilization and Confers Resistance to AR-Targeted Therapies in Advanced Prostate Cancer. Molecular Cancer Therapeutics. 18(10). 1875–1886. 53 indexed citations

10.

Cucchiara, Vito, Joy C. Yang, Chengfei Liu, et al.. (2019). GnRH Antagonists Have Direct Inhibitory Effects On Castration-Resistant Prostate Cancer Via Intracrine Androgen and AR-V7 Expression. Molecular Cancer Therapeutics. 18(10). 1811–1821. 10 indexed citations

11.

Wang, Yongqiang, Zenghong Huang, Chengfei Liu, et al.. (2019). Therapeutic Targeting of MDR1 Expression by RORγ Antagonists Resensitizes Cross-Resistant CRPC to Taxane via Coordinated Induction of Cell Death Programs. Molecular Cancer Therapeutics. 19(2). 364–374. 19 indexed citations

12.

Liu, Chengfei, Cameron M. Armstrong, Wei Lou, et al.. (2017). Niclosamide and Bicalutamide Combination Treatment Overcomes Enzalutamide- and Bicalutamide-Resistant Prostate Cancer. Molecular Cancer Therapeutics. 16(8). 1521–1530. 54 indexed citations

13.

Tummala, Ramakumar, Wei Lou, Allen C. Gao, & Nagalakshmi Nadiminty. (2017). Quercetin Targets hnRNPA1 to Overcome Enzalutamide Resistance in Prostate Cancer Cells. Molecular Cancer Therapeutics. 16(12). 2770–2779. 86 indexed citations

14.

Nadiminty, Nagalakshmi, Ramakumar Tummala, Chengfei Liu, et al.. (2015). NF-κB2/p52:c-Myc:hnRNPA1 Pathway Regulates Expression of Androgen Receptor Splice Variants and Enzalutamide Sensitivity in Prostate Cancer. Molecular Cancer Therapeutics. 14(8). 1884–1895. 100 indexed citations

15.

Chandrasekar, Thenappan, Joy C. Yang, Allen C. Gao, & Christopher P. Evans. (2015). Mechanisms of resistance in castration-resistant prostate cancer (CRPC).. PubMed Central. 4(3). 365–80. 424 indexed citations breakdown →

16.

Zhu, Yezi, Chengfei Liu, Nagalakshmi Nadiminty, et al.. (2013). Inhibition of ABCB1 Expression Overcomes Acquired Docetaxel Resistance in Prostate Cancer. Molecular Cancer Therapeutics. 12(9). 1829–1836. 104 indexed citations

17.

Nadiminty, Nagalakshmi, Ramakumar Tummala, Chengfei Liu, et al.. (2013). NF-κB2/p52 Induces Resistance to Enzalutamide in Prostate Cancer: Role of Androgen Receptor and Its Variants. Molecular Cancer Therapeutics. 12(8). 1629–1637. 156 indexed citations

18.

Nadiminty, Nagalakshmi, Wei Lou, Meng Sun, et al.. (2010). Aberrant Activation of the Androgen Receptor by NF-κB2/p52 in Prostate Cancer Cells. Cancer Research. 70(8). 3309–3319. 91 indexed citations

19.

Nadiminty, Nagalakshmi, Wei Lou, Soo Ok Lee, et al.. (2006). Prostate-Specific Antigen Modulates Genes Involved in Bone Remodeling and Induces Osteoblast Differentiation of Human Osteosarcoma Cell Line SaOS-2. Clinical Cancer Research. 12(5). 1420–1430. 45 indexed citations

20.

Gao, Allen C., Wei Lou, Jin‐Tang Dong, et al.. (2003). Defining regulatory elements in the human KAI1 (CD 82) metastasis suppressor gene. The Prostate. 57(4). 256–260. 13 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact